低收入和中等收入国家COVID-19急性呼吸衰竭与机械通气的实用推荐
该文针对低收入和中等收入国家(LMIC)资源受限环境,提出COVID-19重症/危重症急性呼吸衰竭与机械通气管理的实用推荐。推荐SpO2持续<94%时开始补氧,目标SpO2 88-95%,无连续脉搏血氧监测时可取更高目标。建议对持续低氧患者尝试清醒俯卧位,但需密切监测并有明确失败与升级标准。推荐基于呼吸窘迫征象而非仅难治性低氧血症插管,并密切监测呼吸恶化、恶化时早期插管。推荐小潮气量通气联合基于高FiO2/低PEEP表的FiO2与PEEP管理,反对常规肺复张(仅作为难治性低氧血症的挽救治疗),推荐插管患者难治性低氧血症(PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O)时俯卧位12-16小时,反对多人共用一台呼吸机,推荐每日评估低水平压力支持撤机准备,反对T管试验因气溶胶风险。
要点
- 推荐SpO2持续<94%时开始补氧,目标SpO2 88-95%;无连续脉搏血氧监测而仅有间断监测时建议更高目标。
- 建议对持续低氧患者尝试清醒俯卧位,但需密切监测并有明确失败与升级标准;在人员数量与培训充足处该策略似乎安全。
- 推荐基于呼吸窘迫征象而非仅难治性低氧血症决定插管,并密切监测呼吸恶化、恶化时早期插管。
- 推荐小潮气量通气联合基于高FiO2/低PEEP表的FiO2与PEEP管理;反对常规肺复张,仅作为难治性低氧血症的挽救治疗。
- 推荐插管患者难治性低氧血症(PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O)时俯卧位12-16小时作为ARDS标准治疗;反对共用呼吸机;推荐每日低水平压力支持评估撤机准备,反对T管试验。
适用人群与场景
- 低收入和中等收入国家(LMIC)资源受限环境中,重症或危重症COVID-19成人患者。
诊断标准与关键阈值
- SpO2持续低于94%为开始补充氧的阈值。
- 补充氧目标为SpO2 88-95%;无连续脉搏血氧监测而仅有间断脉搏血氧监测的环境,建议更高目标。
- 难治性低氧血症定义为PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O(用于插管患者俯卧位指征)。
处置流程与药物剂量
- SpO2持续低于94%时开始补充氧,目标SpO2 88-95%;无连续脉搏血氧监测而仅有间断监测时建议更高目标。
- 对持续低氧患者建议尝试清醒俯卧位,但需密切监测并有明确失败与升级标准;在人员数量与培训充足处该策略似乎安全。
- 推荐基于呼吸窘迫征象而非仅难治性低氧血症决定插管,并密切监测呼吸恶化、恶化时早期插管。
- 推荐小潮气量通气联合基于高FiO2/低PEEP表的FiO2与PEEP管理。
- 推荐反对常规使用肺复张手法,除非作为难治性低氧血症的挽救治疗。
- 推荐插管患者难治性低氧血症(PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O)时俯卧位12-16小时作为ARDS标准治疗。
- 推荐反对多例患者共用一台呼吸机。
- 推荐每日评估低水平压力支持的撤机准备;推荐反对使用T管试验,因气溶胶风险。
红旗征与不能漏的情况
- SpO2持续低于94%提示需开始补充氧。
- 难治性低氧血症(PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O)提示需俯卧位12-16小时及考虑肺复张作为挽救治疗。
- 呼吸窘迫征象提示插管指征,而非仅依赖难治性低氧血症;呼吸恶化需早期插管。
研究设计与关键结果
- 本文为针对LMIC资源受限环境的实用推荐集,基于常源于高收入国家资源丰富ICU的证据,指出将这些推荐直接应用于资源受限环境常不切实际。
证据类型、等级与局限
- 证据类型:指南/实用推荐(来源:Am J Trop Med Hyg)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在LMIC资源受限环境,补氧启动阈值可设为SpO2持续<94%,目标SpO2 88-95%,无连续脉搏血氧监测时可取更高目标。
- 插管决策应基于呼吸窘迫征象而非仅难治性低氧血症,并密切监测呼吸恶化、恶化时早期插管。
- 通气管理采用小潮气量联合高FiO2/低PEEP表的FiO2与PEEP管理,不常规肺复张,仅作为难治性低氧血症挽救治疗。
- 插管患者难治性低氧血症(PaO2/FiO2<150 mmHg,FiO2≥0.6且PEEP≥10 cmH2O)时俯卧位12-16小时作为ARDS标准治疗。
- 反对共用呼吸机;撤机准备每日用低水平压力支持评估,反对T管试验因气溶胶风险。
指南或共识出处
- Pragmatic Recommendations for the Management of Acute Respiratory Failure and Mechanical Ventilation in Patients with COVID-19 in Low- and Middle-Income Countries(Am J Trop Med Hyg)。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Management of patients with severe or critical COVID-19 is mainly modeled after care for patients with severe pneumonia or acute respiratory distress syndrome (ARDS) from other causes, and these recommendations are based on evidence that often originates from investigations in resource-rich intensive care units located in high-income countries. Often, it is impractical to apply these recommendations to resource-restricted settings, particularly in low- and middle-income countries (LMICs). We report on a set of pragmatic recommendations for acute respiratory failure and mechanical ventilation management in patients with severe/critical COVID-19 in LMICs. We suggest starting supplementary oxygen when SpO2 is persistently lower than 94%. We recommend supplemental oxygen to keep SpO2 at 88-95% and suggest higher targets in settings where continuous pulse oximetry is not available but intermittent pulse oximetry is. We suggest a trial of awake prone positioning in patients who remain hypoxemic; however, this requires close monitoring, and clear failure and escalation criteria. In places with an adequate number and trained staff, the strategy seems safe. We recommend to intubate based on signs of respiratory distress more than on refractory hypoxemia alone, and we recommend close monitoring for respiratory worsening and early intubation if worsening occurs. We recommend low-tidal volume ventilation combined with FiO2 and positive end-expiratory pressure (PEEP) management based on a high FiO2/low PEEP table. We recommend against using routine recruitment maneuvers, unless as a rescue therapy in refractory hypoxemia, and we recommend using prone positioning for 12-16 hours in case of refractory hypoxemia (PaO2/FiO2 < 150 mmHg, FiO2 ≥ 0.6 and PEEP ≥ 10 cmH2O) in intubated patients as standard in ARDS patients. We also recommend against sharing one ventilator for multiple patients. We recommend daily assessments for readiness for weaning by a low-level pressure support and recommend against using a T-piece trial because of aerosolization risk.
参考来源
- Serpa Neto A, Checkley W, Sivakorn C, et al. Pragmatic Recommendations for the Management of Acute Respiratory Failure and Mechanical Ventilation in Patients with COVID-19 in Low- and Middle-Income Countries. Am J Trop Med Hyg. 2021. PMID: 33534774. doi:10.4269/ajtmh.20-0796
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。